1. Home
  2. STIM vs OABI Comparison

STIM vs OABI Comparison

Compare STIM & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STIM
  • OABI
  • Stock Information
  • Founded
  • STIM 2003
  • OABI 2012
  • Country
  • STIM United States
  • OABI United States
  • Employees
  • STIM N/A
  • OABI N/A
  • Industry
  • STIM Medical/Dental Instruments
  • OABI Biotechnology: Pharmaceutical Preparations
  • Sector
  • STIM Health Care
  • OABI Health Care
  • Exchange
  • STIM Nasdaq
  • OABI Nasdaq
  • Market Cap
  • STIM 232.3M
  • OABI 198.2M
  • IPO Year
  • STIM 2018
  • OABI N/A
  • Fundamental
  • Price
  • STIM $3.46
  • OABI $1.60
  • Analyst Decision
  • STIM Buy
  • OABI Strong Buy
  • Analyst Count
  • STIM 4
  • OABI 3
  • Target Price
  • STIM $6.00
  • OABI $7.00
  • AVG Volume (30 Days)
  • STIM 503.9K
  • OABI 1.1M
  • Earning Date
  • STIM 08-11-2025
  • OABI 08-07-2025
  • Dividend Yield
  • STIM N/A
  • OABI N/A
  • EPS Growth
  • STIM N/A
  • OABI N/A
  • EPS
  • STIM N/A
  • OABI N/A
  • Revenue
  • STIM $89,448,000.00
  • OABI $26,744,000.00
  • Revenue This Year
  • STIM $104.65
  • OABI N/A
  • Revenue Next Year
  • STIM $10.69
  • OABI $45.65
  • P/E Ratio
  • STIM N/A
  • OABI N/A
  • Revenue Growth
  • STIM 22.16
  • OABI 27.07
  • 52 Week Low
  • STIM $0.52
  • OABI $1.22
  • 52 Week High
  • STIM $5.92
  • OABI $4.96
  • Technical
  • Relative Strength Index (RSI)
  • STIM 32.40
  • OABI 54.70
  • Support Level
  • STIM $3.35
  • OABI $1.35
  • Resistance Level
  • STIM $3.90
  • OABI $1.81
  • Average True Range (ATR)
  • STIM 0.18
  • OABI 0.10
  • MACD
  • STIM -0.03
  • OABI 0.04
  • Stochastic Oscillator
  • STIM 17.63
  • OABI 71.96

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

About OABI OmniAb Inc.

OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.

Share on Social Networks: